Newsroom
May 24, 2022
Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Contributed and written by Cliff Despres, Institute for Health Promotion Research SAN ANTONIO (May 24, 2022) — Latinos represent less than 10% of volunteers in cancer clinical trials. The lack of Latinos in clinical trials makes it harder for researchers to find treatments tailored for this group — which […]
April 1, 2022
Daohong Zhou, MD, a professor with tenure in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, has received a UT System Faculty STARs award in the amount of $1,487,563 to support his drug discovery research.
March 31, 2022
The UT Health San Antonio School of Dentistry has partnered with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk on Saturday, April 23, in observance of the 22nd Annual Oral Cancer Awareness Month.
March 28, 2022
Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]
March 18, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 18, 2022) — Ruben A. Mesa, MD, FACP, professor of medicine and executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, testified on clinical trial diversity yesterday (March 17, 2022) before the House Committee on Energy and Commerce. The […]
March 10, 2022
An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]
